Posted by Michael Wonder on 14 Nov 2017
NICE to play key role in UK drug fast-track scheme
14 November 2017 - NICE has been chosen to run the office that will decide which ground-breaking healthcare products will be fast-tracked for approval for use in England’s NHS.
The Accelerated Access Collaborative will co-ordinate actions of national bodies making decisions on drugs and technologies that will be granted access to the proposed fast path to market.
This new Accelerated Access Pathway will come into effect next April, and will select a handful of products each year that will be given special priority, hastening clinical development and offering an expedited route to market.
